EdgeMarketInstruments › TECX

TECX — Tectonic Therapeutic, Inc.

US Healthcare Pharma & biotech equity mkt cap 704.8M
37.63 +4.38% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 14.71 · high 37.93

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-06-21.

Performance

1 day+4.38%
1 week+7.79%
1 month+19.04%
3 months+31.94%
6 months+76.09%
Year to date+79.96%
1 year+56.27%
3 years+104.96%
5 years-47.47%

Technicals

RSI 1472.9
vs 50-day avg+16.37%
vs 200-day avg+41.48%
Volatility 1y82.7%
Max drawdown 1y-44.62%
Avg volume 30d196.6K
Daily bars held2,053
History from2018-06-21

Measured signals that fired on TECX

datesignal measured base rate
2026-07-02Breakout to a 52-week high
price
-1.00% over 21 days · t = -8.58 · n = 24,386
statistically distinguishable from its control group
2026-03-04Breakout to a 52-week high
price
-1.00% over 21 days · t = -8.58 · n = 24,386
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-08-12McNamara Peter
Chief Scientific Officer
Open-market sale 10b5-1 plan4335.001.5K
2026-08-12McNamara Peter
Chief Scientific Officer
Option exercise 10b5-1 plan4314.71633
2026-06-30McNamara Peter
Chief Scientific Officer
Open-market sale 10b5-1 plan17235.006.0K
2026-06-30McNamara Peter
Chief Scientific Officer
Option exercise 10b5-1 plan17214.712.5K
2026-06-20REICIN ALISE
Chief Executive Officer
Shares withheld for tax92430.3428.0K
2026-05-04Ruddy Marcella K.
Chief Medical Officer
Open-market sale 10b5-1 plan1.1K30.0031.9K
2026-04-01Ruddy Marcella K.
Chief Medical Officer
Open-market sale 10b5-1 plan1.0K31.0531.1K
2026-03-06Ruddy Marcella K.
Chief Medical Officer
Open-market sale 10b5-1 plan10.0K30.00300.0K
2026-03-06McNamara Peter
Chief Scientific Officer
Open-market sale 10b5-1 plan6.0K30.00181.4K
2026-03-06McNamara Peter
Chief Scientific Officer
Open-market sale 10b5-1 plan21535.007.5K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
FMR LLC87.1M2.8M
TCG Crossover Management, LLC37.2M1.2M
Aberdeen Group plc35.3M1.1M
BlackRock, Inc.26.6M860.4K
BRAIDWELL LP26.2M847.2K
First Light Asset Management, LLC20.0M647.7K
BAKER BROS. ADVISORS LP18.8M607.8K
5AM Venture Management, LLC18.8M606.7K
VANGUARD CAPITAL MANAGEMENT LLC14.6M473.5K
Vestal Point Capital, LP10.1M328.0K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
1442026-08-21on EDGAR ↗
42026-08-142026-08-12on EDGAR ↗
1442026-08-12on EDGAR ↗
10-Q2026-08-062026-06-30on EDGAR ↗
8-K2026-08-062026-08-06on EDGAR ↗
42026-07-012026-06-30on EDGAR ↗
1442026-06-30on EDGAR ↗
42026-06-232026-06-20on EDGAR ↗

Short selling

Avg short volume, 90d43.1% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Ask the AI about TECX

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open TECX in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →